Plus Therapeutics, Inc.
PSTV
$5.50
-$0.03-0.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 56.00% | -72.49% | -59.69% | -43.82% | -130.36% |
| Total Depreciation and Amortization | -54.57% | -44.95% | 15.96% | 39.27% | 43.68% |
| Total Amortization of Deferred Charges | -- | -- | -140.00% | -121.98% | -111.43% |
| Total Other Non-Cash Items | -140.38% | 529.46% | 562.79% | 1,642.30% | 1,281.56% |
| Change in Net Operating Assets | -248.36% | -287.49% | -195.22% | -226.28% | 353.75% |
| Cash from Operations | -70.65% | -96.84% | -40.14% | -69.58% | -5.55% |
| Capital Expenditure | -709.17% | 54.11% | 72.88% | 79.77% | -5.83% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10,866.36% | 79.39% | 107.55% | 74.93% | 66.05% |
| Cash from Investing | -6,749.21% | 79.23% | 106.81% | 75.84% | 55.74% |
| Total Debt Issued | -75.11% | 36.33% | 13.55% | 13.55% | -- |
| Total Debt Repaid | 89.61% | -75.05% | -59.05% | -45.73% | -558.52% |
| Issuance of Common Stock | -0.40% | 427.24% | 376.59% | 76.56% | 395.94% |
| Repurchase of Common Stock | -- | -- | 100.00% | 91.00% | 91.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -3,125.68% | 55.47% | 100.00% |
| Cash from Financing | 39.10% | 389.91% | 386.18% | 85.88% | 790.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -198.26% | 202.41% | 223.34% | 55.22% | 170.92% |